12. Gene Expression Tests for Women with Early Stage Breast Cancer: A Review ofClinical Utility and Cost-Effectiveness [Internet].Narain T, Adcock L.Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Oct.CADTH Rapid Response Reports.While each gene expression test has been independently clinically validated usingprospective or retrospective evidence, currently, there is no gold-standard forbreast cancer gene expression tests. This highlights the need for comparativeassessments of clinical utility and cost-effectiveness.PMID: 30020587 